A Randomised, Double Blind, Placebo Controlled, Parallel-group Study With Use of Budesonide/Formoterol "As-needed", or Terbutaline "As-needed" or Regular Use of Budesonide + Terbutaline "As-needed", in Patients With Mild Intermittent Asthma.

Trial Profile

A Randomised, Double Blind, Placebo Controlled, Parallel-group Study With Use of Budesonide/Formoterol "As-needed", or Terbutaline "As-needed" or Regular Use of Budesonide + Terbutaline "As-needed", in Patients With Mild Intermittent Asthma.

Completed
Phase of Trial: Phase II

Latest Information Update: 03 Oct 2013

At a glance

  • Drugs Budesonide/formoterol (Primary) ; Budesonide; Terbutaline
  • Indications Exercise-induced asthma
  • Focus Therapeutic Use
  • Acronyms MIA
  • Sponsors AstraZeneca
  • Most Recent Events

    • 28 Sep 2011 Results presented at the 21st Annual Congress of the European Respiratory Society.
    • 18 Nov 2010 Status changed from not yet recruiting to completed as reported by ClinicalTrials.gov.
    • 09 Oct 2009 New trial record
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top